Wes Childs, senior director for engineering at IDBS, highlights how the cloud can help organisations accelerate drug discovery
This webcast will provide insights on how scientists and research organisations are using, or planning to use, cloud technologies, to advance their groundbreaking research
Rob Lalonde, Univa’s cloud VP general manager, considers the unique challenges posed by HPC
As cloud technology matures, the options for HPC users continue to expand, writes Robert Roe
Robert Roe looks at use cases for cloud technology in HPC
Cloud-based informatics software is growing fast thanks to highly flexible and customisable deployment methods, writes Sophia Ktori
Robert Roe looks at the changing ways that the HPC industry uses cloud computing technology
AMD has announced the availability of the first AMD EPYCTM processor-based instance on Oracle Cloud Infrastructure.
Datrium, a provider of hybrid cloud computing and data management, has announced that it has closed an oversubscribed $60M round of Series D funding
vScaler has announced its continued listing under G-Cloud 10 with its Infrastructure as a Service (IaaS) offering
Elsevier and ExactCure recently announced a collaboration to develop and offer to hospitals – without charge – drug-specific exposure models for 20 already approved medicines that are being tested as potential treatments for Covid-19.
With the world’s focus on the COVID-19 pandemic, LIMS providers are working to develop solutions tailored to assist in the testing and management of virus samples.
Researchers at Harvard Medical School (HMS) have released an open source drug discovery platform, VirtualFlow, that harnesses supercomputing power to screen potentially billions of small organic compound structures in parallel, in the hunt for promising new drug molecules.
When designing a component or system, where do you start? In days gone by, designers would literally go back to the drawing board, using their experience and expertise to develop a new concept.
Effective utilisation of computing tools is critical to both AI and HPC research, with recent projects in both fields highlighting the scientific benefit of carefully managing resources.
Advances in computer vision combined with AI computing are helping pathologists to more accurately identify subtypes of cancer - leading to better treatments for patients, explains Dan Ruderman.
